Shiv Grewal
Senior executive and dealmaker with over 30 years of US and cross border experience. Mr. Grewal is known for negotiating some of the most prominent cross border life science, technology, clean tech. and financial services transactions on the west coast. He also works with several venture funds who seek to invest in new and existing companies in the US and throughout Asia. Auctus Global Capital partners with emerging growth businesses in clean technology, life sciences, and information technology. Acting as a unique investment and development partner, it focuses on cross-border transactions throughout Asia by connecting U.S. companies to entities in Japan, China and India and by leveraging capital from Asia to invest in U.S. entities. Auctus is launching a fund that will target opportunistic investments. In addition, it has launched an incubator at the University of California, Irvine, that focuses on medical device companies and healthcare technologies.